Catherine Miller

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Patient Reported

Multiple Sclerosis

Placebo Controlled

Top Venues

Therapeutic advances in neurological disorders

Neurology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob Liseno, Brittney Lager, Catherine Miller, Sai L Shankar, Jason P Mendoza, James B Lewin
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence. Neurology and therapy 10 (1) (2021)
Annette Wundes, Sibyl Wray, Ralf Gold, Barry A Singer, Elzbieta Jasinska, Tjalf Ziemssen, Jerome de Seze, Pavle Repovic, Hailu Chen, Jerome Hanna, Jordan Messer, Catherine Miller, Robert T Naismith
Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. Therapeutic advances in neurological disorders 14 (2021)
Ralf Gold, Douglas L Arnold, Amit Bar-Or, Robert J Fox, Ludwig Kappos, Chongshu Chen, Becky Parks, Catherine Miller
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE. Therapeutic advances in neurological disorders 13 (2020)